Xerimis

Xerimis is uniquely positioned to service the specific needs of small to mid-sized pharmaceutical companies. We know that the task of a modern day clinical packaging organization demands excellence in two key areas: an industry-leading knowledge of the landscape and its complexities along with a tireless dedication to client needs. At Xerimis, we understand the unique demands of your project, and we're here, alongside you, every step of the way. Phase 1 trials are the building blocks needed for all successful drug compounds. We work with our clients to develop the most user friendly designs to help ensure that the right drug is dispensed correctly at the right time. Phase 2 trials bring more complexity and critical packaging decisions to the clinical development team. You can rely on Xerimis to help guide you through this process. Phase 3 trials typically draw on a large number of global sites to fill the enrollment needs of the study. Xerimis has extensive experience with global Phase 3 trials. The benefits of an international player with the agility of something much more personal. We're constantly striving to provide our clients with a better, more comprehensive experience, and DashX is our latest evolution in fulfilling on that promise.